Sep 16, 2019
DiscGenics' U.S. Clinical Study of Cell Therapy for Disc Degeneration Passes Halfway Mark
Jun 19, 2019
Bayer's Stivarga® (regorafenib) becomes first compound used in clinical trial platform to investigate new therapies for brain cancer
May 14, 2019
Mallinckrodt Completes Enrollment of Phase 3 Terlipressin CONFIRM Trial
Apr 29, 2019
Wize Pharma Announces Positive Results in First Controlled Study of Treatment for Dry Eye Syndrome in Patients With Conjunctivochalasis
Apr 24, 2019
Young Blood Plasma Parkinson's Disease Investigation Three-Month Results Show Dramatic Improvements in Every Neurological Assessment Category
Apr 11, 2019
InDex Pharmaceuticals Provides Status Update on the Patient Recruitment in the CONDUCT Study
Mar 11, 2019
Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia
Feb 28, 2019
A University of Nebraska-Lincoln Clinical Trial on Natreon's Patented PrimaVie® (Shilajit) Showed Increased Retention of Muscular Strength and Decreased Hydroxyproline
Feb 05, 2019
Study Shows Kemin Industries' Neumentix(TM) Supports Physical Performance
Jan 15, 2019
New Drug Application for Insomnia Disorder Treatment Lemborexant Submitted in the United States
Jan 09, 2019
New England Journal of Medicine publishes positive results of the pivotal trial of Cablivi® (caplacizumab) for rare blood clotting disorder
Jan 02, 2019
Aevi Genomic Medicine Announces Top-Line Results from Placebo-Controlled ASCEND Trial (Parts A & B) of AEVI-001 in Children with ADHD
Dec 23, 2018
HistoIndex's Second Harmonic Generation (SHG) Technology: A Potentially Important Tool Used In Madrigal's Phase 2 Nonalcoholic Steatohepatitis (NASH) Clinical Trial
Dec 17, 2018
Natreon's Sensoril® Ashwagandha Improves Strength Training Adaptations and Recovery in Recently Published Clinical Trial
Dec 10, 2018
Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
Nov 09, 2018
Mallinckrodt Presents Terlipressin Clinical Data at The Liver Meeting® 2018
Nov 07, 2018
Endo Announces Positive Results from Phase 3 Studies of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite
Oct 19, 2018
InDex Pharmaceuticals Publishes Post-hoc Analysis of the COLLECT Study
Oct 05, 2018
Xencor Announces Topline Results from Phase 2 Study of XmAb®5871 in Systemic Lupus Erythematosus and Selection of Late-Breaking Abstract for Presentation at the 2018 ACR Annual Meeting
Aug 09, 2018
InDex Pharmaceuticals Updates Timeline for Top Line Results from the CONDUCT Study to First Half of 2019